Active substanceEthionamideEthionamide
Similar drugsTo uncover
  • Miobid-250
    pills inwards 
  • Ethid
    pills inwards 
    Lupine Co., Ltd.     India
  • Ethomide
    pills inwards 
  • Dosage form: & nbspcoated tablets
    Composition:

    active substance: ethionamide USP 250 mg;

    Excipients: calcium phosphate disubstituted, dihydrate, corn starch, gelatin, sodium benzoate, magnesium stearate, talc, microcrystalline cellulose,

    Shell: hydroxypropylmethylcellulose E5, hydroxypropylmethylcellulose E15, polyethylene glycol, talc, titanium dioxide, iron oxide yellow.

    Description:tablets, film-coated, yellow, round, biconvex.
    Pharmacotherapeutic group:antituberculous.
    ATX: & nbsp

    J.04.A.D   Derivatives of thiourea

    J.04.A.D.03   Ethionamide

    Pharmacodynamics:

    The anti-tuberculosis drug of the second series acts bacteriostatically (suppresses the synthesis of peptides of mycobacteria). Oppresses the growth and multiplication of mycobacterium tuberculosis with intracellular and extracellular location (including refractory and atypical forms). Strengthens phagocytosis in the focus of tuberculous inflammation, which contributes to its resorption. During treatment, the bacteriostatic activity of the drug is reduced.

    Pharmacokinetics:

    Absorption is high.The time to reach the maximum concentration in the blood (Tcmax) is 1-3 hours. It penetrates well into tissues and organs, as well as into spinal fluid. Metabolised in the liver. Excretion with bile - 70-80%, kidneys - 20-30% (less than 1% - unchanged).

    Indications:

    Etide is used to treat all forms of tuberculosis, including, with resistance of the pathogen to other anti-tuberculosis drugs (I series) or their intolerance, including in the complex tuberculostatic therapy.

    Contraindications:Ethid should not be used with individual hypersensitivity to ethionamide, and so on. to other components of the drug, during pregnancy and lactation, liver failure, acute gastritis, gastric ulcer and duodenal ulcer, erosive-ulcerative colitis, acute hepatitis, liver cirrhosis, chronic alcoholism.
    Carefully: diabetes mellitus, epilepsy.
    Pregnancy and lactation:contraindicated
    Dosing and Administration:

    Take the drug inside after eating. Adults appoint 0.25 g 3 times a day; at good tolerability - 0.5 g 2 times a day. In patients older than 60 years and with a body weight of less than 50 kg, the daily dose should not exceed 0.75 g (more often prescribed 0.25 g twice daily). Children are prescribed at the rate of 10-20 mg / kg of body weight per day.

    Side effects:

    Side effects of Etide are manifested from the side of the gastrointestinal tract, liver, skin, endocrine and nervous system.

    On the part of the gastrointestinal tract: loss of appetite, nausea, vomiting, dry mouth or hypersalivation, a "metallic" taste in the mouth. After the withdrawal of the drug, these phenomena tend to quickly pass.

    Often during treatment there is an increase in activity of "liver" transaminases. Rare violations of liver function with signs of hepatitis and jaundice are rare. Hepatotoxicity of the drug depends on the existing violations of liver function, such as liver damage due to alcoholism or after surgery. These side effects are especially noted with combined therapy with isoniazid, rifampicin and pyrazinamide.

    Skin reactions are rare, in some cases described pellagrope-like reactions in combination with violations from the central nervous system.

    Sometimes there are violations of the endocrine system. Along with the development of hypoglycemia (a decrease in blood glucose less than 50 mg%) in patients with diabetes, described the development of gynecomastia (an increase in mammary glands in men).

    Rarely there is a violation of the menstrual cycle and impotence, as well as hypothyroidism (a decrease in thyroid function).

    The ethid can sometimes cause disturbances from the peripheral and central nervous systems. In a combination with isoniazid cases of polyneuropathy are described. Taking Etid can cause dizziness, headaches, weakness, impaired concentration, mental disorders. Rarely, optic neuritis, tachycardia. Simultaneous reception of other antituberculosis drugs acting on the central nervous system, such as isoniazid or cycloserine, can lead to an increase in side effects from the central nervous system. The same effect can have a simultaneous reception of alcohol. In some cases, allergic reactions and disorders of the bone marrow are described.

    Interaction:

    With combined therapy of tuberculosis, the additive hepatotoxic effect of individual drugs should be taken into account. This is particularly true for the combination of Ethid with isoniazid, rifampicin and pyrazinamide. Additive effect on the central nervous system is observed when isoniazid and cycloserine are used together (especially in patients,who have a history of neurological or mental disorders).

    Simultaneous reception of alcohol leads to depression of the central nervous system. In certain cases, when taking Etid, it is necessary to reduce a dose of insulin or oral antidiabetic drugs used for ingestion.

    Special instructions:

    Before treatment with Etide and every 2-4 weeks, it is necessary to monitor the activity of "liver" transaminases in the blood plasma. In the case of combined use with pyrazinamide, more frequent monitoring of liver function is required.

    Before appointment, it is necessary to determine in vitro the sensitivity of a newly isolated culture Mycobacterium tuberculosis to the drug.

    Combined use with protionamide is not advisable, because mycobacteria tuberculosis has a cross-resistance to these drugs.

    It should avoid joint taking drugs that have a hepatotoxic effect.

    During treatment with Etidom, it is necessary to prescribe pyridoxine.

    Effect on the ability to drive transp. cf. and fur:

    Form release / dosage:

    For 10 tablets in aluminum strips.

    Packaging:

    For 5 strips in a cardboard box with instructions for use.For 100 tablets in a bag of polyethylene in a plastic container with instructions for use. For 500 tablets in a bag of polyethylene in a plastic container with instructions for use.

    Storage conditions:List B. In a place protected from light and inaccessible to children, at a temperature of no higher than 30 ° C.
    Shelf life:

    3 years.

    Do not use after the expiry date printed on the package.

    Terms of leave from pharmacies:On prescription
    Registration number:П N015296 / 01
    Date of registration:03.10.2008
    The owner of the registration certificate:Lupine Co., Ltd.Lupine Co., Ltd. India
    Manufacturer: & nbsp
    Representation: & nbspLUPIN LIMITEDLUPIN LIMITED
    Information update date: & nbsp06.10.2015
    Illustrated instructions
      Instructions
      Up